Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation

Geahča maid

• Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
  Dahkki: Haynes, R, et al.
  Almmustuhtton: (2014)
• Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
  Dahkki: Haynes, R, et al.
  Almmustuhtton: (2014)
• Effect of alemtuzumab or basiliximab induction therapy on graft function and survival of kidneys from donors after cardiac death.
  Dahkki: Plata-Munoz, J, et al.
  Almmustuhtton: (2009)
• Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
  Dahkki: Masashi Furukawa, et al.
  Almmustuhtton: (2022-06-01)
• Elective conversion to sirolimus vs. continued tacrolimus in kidney transplantation (the 3c study): Results of a randomized trial
  Dahkki: Haynes, R, et al.
  Almmustuhtton: (2017)